Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dr. Fooke (Dr. Fooke-Achterrath Laboratorien GmbH) is a specialized German biotechnology company focused on the development and production of in vitro diagnostic (IVD) systems for allergy and autoimmune diseases. Founded in 1992 and based in Neuss, the company is widely recognized for its proprietary Allergy Lateral Flow Assay (ALFA) platform, which provides rapid and flexible screening for allergen-specific IgE antibodies. In addition to its lateral flow technology, Dr. Fooke offers a comprehensive portfolio of ELISA and immunoblot test systems designed for clinical laboratory use. The company also provides automated solutions to streamline diagnostic workflows in immunology. Dr. Fooke serves a global market, providing high-quality tools for the precise diagnosis of Type I allergies and various autoimmune conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Focke.